These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 27325476)

  • 21. Effects of minimum monitor unit threshold on spot scanning proton plan quality.
    Howard M; Beltran C; Mayo CS; Herman MG
    Med Phys; 2014 Sep; 41(9):091703. PubMed ID: 25186378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
    Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
    Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma.
    Madani I; Lomax AJ; Albertini F; Trnková P; Weber DC
    Radiat Oncol; 2015 Mar; 10():72. PubMed ID: 25890217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An analytical dose-averaged LET calculation algorithm considering the off-axis LET enhancement by secondary protons for spot-scanning proton therapy.
    Hirayama S; Matsuura T; Ueda H; Fujii Y; Fujii T; Takao S; Miyamoto N; Shimizu S; Fujimoto R; Umegaki K; Shirato H
    Med Phys; 2018 Jul; 45(7):3404-3416. PubMed ID: 29788552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Full Monte Carlo-Based Biologic Treatment Plan Optimization System for Intensity Modulated Carbon Ion Therapy on Graphics Processing Unit.
    Qin N; Shen C; Tsai MY; Pinto M; Tian Z; Dedes G; Pompos A; Jiang SB; Parodi K; Jia X
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):235-243. PubMed ID: 29079118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An algorithm to assess the need for clinical Monte Carlo dose calculation for small proton therapy fields based on quantification of tissue heterogeneity.
    Bueno M; Paganetti H; Duch MA; Schuemann J
    Med Phys; 2013 Aug; 40(8):081704. PubMed ID: 23927301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison.
    Kandula S; Zhu X; Garden AS; Gillin M; Rosenthal DI; Ang KK; Mohan R; Amin MV; Garcia JA; Wu R; Sahoo N; Frank SJ
    Med Dosim; 2013; 38(4):390-4. PubMed ID: 23916884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single-field integrated boost treatment planning technique for spot scanning proton therapy.
    Zhu XR; Poenisch F; Li H; Zhang X; Sahoo N; Wu RY; Li X; Lee AK; Chang EL; Choi S; Pugh T; Frank SJ; Gillin MT; Mahajan A; Grosshans DR
    Radiat Oncol; 2014 Sep; 9():202. PubMed ID: 25212571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of a hybrid Monte Carlo-Pencil Beam dose algorithm for proton therapy inverse planning.
    Barragán Montero AM; Souris K; Sanchez-Parcerisa D; Sterpin E; Lee JA
    Med Phys; 2018 Feb; 45(2):846-862. PubMed ID: 29159915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images.
    Kurz C; Nijhuis R; Reiner M; Ganswindt U; Thieke C; Belka C; Parodi K; Landry G
    Radiat Oncol; 2016 Apr; 11():64. PubMed ID: 27129305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robust Intensity Modulated Proton Therapy (IMPT) Increases Estimated Clinical Benefit in Head and Neck Cancer Patients.
    van Dijk LV; Steenbakkers RJ; ten Haken B; van der Laan HP; van 't Veld AA; Langendijk JA; Korevaar EW
    PLoS One; 2016; 11(3):e0152477. PubMed ID: 27030987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
    Bai X; Lim G; Grosshans D; Mohan R; Cao W
    Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moving GPU-OpenCL-based Monte Carlo dose calculation toward clinical use: Automatic beam commissioning and source sampling for treatment plan dose calculation.
    Tian Z; Li Y; Hassan-Rezaeian N; Jiang SB; Jia X
    J Appl Clin Med Phys; 2017 Mar; 18(2):69-84. PubMed ID: 28300376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking.
    Munck Af Rosenschöld P; Engelholm S; Ohlhues L; Law I; Vogelius I; Engelholm SA
    Acta Oncol; 2011 Aug; 50(6):777-83. PubMed ID: 21767174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing cone-beam CT intensity correction methods for dose recalculation in adaptive intensity-modulated photon and proton therapy for head and neck cancer.
    Kurz C; Dedes G; Resch A; Reiner M; Ganswindt U; Nijhuis R; Thieke C; Belka C; Parodi K; Landry G
    Acta Oncol; 2015; 54(9):1651-7. PubMed ID: 26198654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reoptimization of Intensity Modulated Proton Therapy Plans Based on Linear Energy Transfer.
    Unkelbach J; Botas P; Giantsoudi D; Gorissen BL; Paganetti H
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1097-1106. PubMed ID: 27869082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility and robustness of dose painting by numbers in proton therapy with contour-driven plan optimization.
    Barragán AM; Differding S; Janssens G; Lee JA; Sterpin E
    Med Phys; 2015 Apr; 42(4):2006-17. PubMed ID: 25832091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporating deliverable monitor unit constraints into spot intensity optimization in intensity-modulated proton therapy treatment planning.
    Cao W; Lim G; Li X; Li Y; Zhu XR; Zhang X
    Phys Med Biol; 2013 Aug; 58(15):5113-25. PubMed ID: 23835656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric feasibility of intensity modulated proton therapy in a transverse magnetic field of 1.5 T.
    Hartman J; Kontaxis C; Bol GH; Frank SJ; Lagendijk JJ; van Vulpen M; Raaymakers BW
    Phys Med Biol; 2015 Aug; 60(15):5955-69. PubMed ID: 26182957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.
    Guan F; Peeler C; Bronk L; Geng C; Taleei R; Randeniya S; Ge S; Mirkovic D; Grosshans D; Mohan R; Titt U
    Med Phys; 2015 Nov; 42(11):6234-47. PubMed ID: 26520716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.